Colin Shannon's Net Worth

$142 Million

Estimate Recalculated Sep 8, 2024 07:34PM EST

Who is Colin Shannon?

Colin Shannon has an estimated net worth of $142 Million. This is based on reported shares across multiple companies, which include PRA International, PRA Health Sciences, Inc., and PHARMACEUTICAL PRODUCT DEVELOPMENT INC.

SEC CIK

Colin Shannon's CIK is 0001285101

Past Insider Trading and Trends

2021 was Colin Shannon's most active year for acquiring shares with 10 total transactions. Colin Shannon's most active month to acquire stocks was the month of May. 2021 was Colin Shannon's most active year for disposing of shares, totalling 32 transactions. Colin Shannon's most active month to dispose stocks was the month of June. 2021 saw Colin Shannon paying a total of $23,214,015.16 for 729,788 shares, this is the most they've acquired in one year. In 2021 Colin Shannon cashed out on 1,699,007 shares for a total of $115,867,450.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PRA International No price found

Pres/Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
May 7
Form 3
—
0
—
—
0
No matching records found

PRA Health Sciences, Inc. No price found

President & CEO

Colin Shannon used to own units in Common Stock but no longer holds any shares there.acquired a total of 1,493,140 shares in PRA Health Sciences, Inc. at a cost of $26,589,998.83, Colin also disposed a total of 1,498,503 shares of PRA Health Sciences, Inc. equalling to $165,692,580.29.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-46.50K
—
—
0
Jul 1
Form 4/A
-14.88%
-8.13K
$166.58
-$1,353,611.30
46.5K
Scheduled
Jun 16
Form 4
—
0
$107.70
-$54,012,747.65
54.63K
Scheduled
Jun 17
Form 4
-15.89%
-10.32K
$89.67
-$36,184,264.77
54.63K
Scheduled
Jun 15 - Jun 16
Form 4
+14.08%
8.02K
$170.45
-$1,102,811.50
64.94K
Jun 1
Form 4
-9.64%
-6.07K
$102.88
-$624,790.24
56.93K
Aug 13
Form 4
—
0
—
—
0
Jun 1
Form 4
+110.00%
33K
—
—
63K
Aug 13
Form 4
∞
30K
—
—
30K
Aug 16
Form 4
—
0
—
—
0
Aug 29
Form 4
-100.00%
-400.00K
$74.85
-$29,940,000.00
0
Aug 14
Form 4
∞
400K
$5.85
$2,339,980.59
400K
Aug 8
Form 4
—
0
$33.47
-$3,053,000.00
0
Scheduled
Mar 28
Form 4
—
0
$32.22
-$5,856,000.00
0
Scheduled
Feb 21 - Feb 23
Form 4
—
0
$27.25
-$5,833,829.64
0
Aug 18 - Aug 22
Form 4/A
-6.51%
-5.36K
$42.26
-$226,640.38
77.02K
Mar 2
Form 4
-100.00%
-77.02K
$42.26
-$3,254,822.94
0
Mar 8
Form 4
∞
77.02K
$24.06
-$43.63
77.02K
Mar 2
Form 3
—
0
—
—
0
No matching records found

PHARMACEUTICAL PRODUCT DEVELOPMENT INC No price found

EVP, Global Clinical Ops

Colin Shannon used to own units in Common Stock but no longer holds any shares there. From 2004 to 2007 Colin Shannon acquired a total of 154,295 shares in PHARMACEUTICAL PRODUCT DEVELOPMENT INC at a cost of $3,373,654.81, Colin also disposed a total of 154,295 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC equalling to $6,266,573.11.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$25.28
-$190,438.16
0
May 4
Form 4
—
0
$27.67
-$420,824.14
0
Feb 9
Form 4
—
0
$26.90
-$1,210,653.34
0
Oct 20
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
$44.87
-$1,012,123.52
0
Jul 19 - Jul 20
Form 4
—
0
—
—
0
Nov 16
Form 4
—
0
$28.61
-$58,879.14
0
Jul 22
Form 4
—
0
—
—
0
Jul 16
Form 3
—
0
—
—
0
No matching records found